Join Rad-Cast as we welcome Dr. Richard Fleming! Dr.Fleming will detail his research and methods that show the ability to measure changes in growth rates through the transitional and cancer growth cycles. Dr. Fleming discusses FMTVDM, the first patented method which quantifies results. Through calibration, enhancement and quantification, it is possible to measure the extent of heart disease and breast cancer. This is truly a phenomenal breakthrough in diagnosis and treatment of cancer [and cardiac] implications.